Meno Essential™
Pre-Order for dispatch from 14th of July.
A plant-derived extract clinically studied in two independent, randomised, double-blind, placebo-controlled trials to relieve multiple menopause symptoms and maintain natural hormonal balance.
Meno Essential™ addresses the underlying endocrine shifts of menopause — not just the symptoms. Formulated with SheVari4®, a proprietary Asparagus racemosus root extract standardised to ≥5% Shatavarin IV, it delivers clinically studied relief across vasomotor, psychological, physical, and sexual domains at a single daily dose of 100 mg.
This non-hormonal formulation acts on the HPA and HPG axes, delivering measurable improvements in both symptom severity and endocrine markers.
Pre-Order for dispatch from 14th of July.
A plant-derived extract clinically studied in two independent, randomised, double-blind, placebo-controlled trials to relieve multiple menopause symptoms and maintain natural hormonal balance.
Meno Essential™ addresses the underlying endocrine shifts of menopause — not just the symptoms. Formulated with SheVari4®, a proprietary Asparagus racemosus root extract standardised to ≥5% Shatavarin IV, it delivers clinically studied relief across vasomotor, psychological, physical, and sexual domains at a single daily dose of 100 mg.
This non-hormonal formulation acts on the HPA and HPG axes, delivering measurable improvements in both symptom severity and endocrine markers.
Original: $33.36
-65%$33.36
$11.68Description
Pre-Order for dispatch from 14th of July.
A plant-derived extract clinically studied in two independent, randomised, double-blind, placebo-controlled trials to relieve multiple menopause symptoms and maintain natural hormonal balance.
Meno Essential™ addresses the underlying endocrine shifts of menopause — not just the symptoms. Formulated with SheVari4®, a proprietary Asparagus racemosus root extract standardised to ≥5% Shatavarin IV, it delivers clinically studied relief across vasomotor, psychological, physical, and sexual domains at a single daily dose of 100 mg.
This non-hormonal formulation acts on the HPA and HPG axes, delivering measurable improvements in both symptom severity and endocrine markers.
